https://european-biotechnology.net/wp-content/uploads/2024/08/Bavarian-Nordic-production-site-in-kvistgaard.jpg
317
634
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-08-16 08:37:002024-08-16 08:37:00Bavarian Nordic A/S applies for EU label extension of mpox vaccine
https://european-biotechnology.net/wp-content/uploads/2024/08/Christian_Wojczewski_16-9.jpg
540
960
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-08-15 10:20:172024-08-19 16:32:03Evotec axes 400 jobs worldwide
https://european-biotechnology.net/wp-content/uploads/2024/08/Nitrogenase-e1723631271837.jpeg
393
700
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-08-15 06:14:552024-08-15 06:14:55Nitrogenases also can fix CO2
https://european-biotechnology.net/wp-content/uploads/2024/08/penKid-measurement_tg-e1723451171706-1030x580-1.png
580
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-08-12 08:30:302024-08-12 08:30:30Sphingotec secures Series C financing
https://european-biotechnology.net/wp-content/uploads/2024/08/Nathaniel-Martin_university-Leiden-1-e1723134154448-1030x581-1.jpg
581
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-08-08 16:19:352024-08-08 16:19:35New antibiotic breaks resistance
https://european-biotechnology.net/wp-content/uploads/2024/08/Sangamo-Roche-MOA.png
424
918
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-08-07 06:52:242024-08-07 06:52:24Roche inks US$2bn biobucks deal with Sangamo
https://european-biotechnology.net/wp-content/uploads/2024/08/carbios-ur-architectural-view.jpg
540
960
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-08-06 10:02:072024-08-06 10:02:07Carbios SAS to expand PET recycling portfolio to the UK
https://european-biotechnology.net/wp-content/uploads/2024/08/ADAPTIMMUNE-MAGEA4-e1722840048633-1030x578-1.png
578
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-08-05 06:41:212024-08-05 06:41:21FDA approves cell therapy for solid tumours
https://european-biotechnology.net/wp-content/uploads/2024/08/Shigella-e1722501749960.png
274
487
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-08-01 08:43:372024-08-01 08:43:37Valneva licences LimmaTech’s Shigella vaccine
https://european-biotechnology.net/wp-content/uploads/2024/07/SIAT-1030x348-1.png
348
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-07-31 06:09:382024-07-31 06:09:38BI Venture Funds invests in oncolytic bacteria
Scroll to top
